Molecular weight: 3647.28
Peptide purity: > 98.0%
Appearance: White powder
Related substance: Total Impurities(%) < 2.0%
Acetate content: < 15.0%
Bacterial Endotoxins: <5 IU/mg
2 mg / 1 vial
5 vial / 1 box
CJC 1295 shown some amazing results as a growth hormone releasing hormone (GHRH) analog. Not only has CJC-1295 shown the ability to increase growth hormone and IGF-I secretion and its benefits, but it has been able to do so in very large amounts. Recent research studies have shown that CJC – 1295 stimulates GH and IGF-1 Secretion, and will keep a steady increase of HGH and IGF-1 with no increase in prolactin, leading to intense fat loss, and increases protein synthesis.
CJC 1295 with dac (synonym CJC1295/DAC, modified form (GRF 1-29) with drug affinity complex) belongs to class of tetrasubtituted peptide hormones and contains 30 amino acids; Also it can be described as analog of GH releasing hormone. Its molecular formula is C165H269N47O46 and its molecular mass is 3647.28.
CJC 1295 with DAC-complex was the first time developed and produced by Canadian scientists with initial purpose to find way to increase effective half-life period of growth hormone release hormone. The very first clinical studies regarding this research compound took place in the year of 2000. In 2006 a study concerning efficacy and effectiveness as well as safety profile of CJC 1295/DAC was done, it includes two double-blind, randomized, placebo-controlled trials. Due to having DAC-complex this research compound possesses greater binding affinity towards GHRH receptors, which in turn protects that hormone from degradation.